Vaccine investment strategy determines which vaccines GAVI
offers to countries. Vaccines recommended in 2008 target
cervical cancer, Japanese encephalitis, rubella, and typhoid. In
2013 GAVI will develop a new vaccine investment strategy for the
period 2014-2019. As part of its future vaccine investment
strategy, GAVI has prioritised human papillomavirus (HPV)
vaccines, which help protect women from cervical cancer. In the
past 10 years, GAVI has successfully helped increase developing
countries' access to life-saving vaccines against hepatitis B,
Haemophilus influenzae type b (Hib), yellow fever, measles 2nd
dose and, most recently, rotavirus and pneumococcal diseases.
The Alliance's Vaccine Investment Strategy, developed in 2008,
considered additional support for vaccines that offer protection
from other deadly infections. The vaccines that were
prioritized, which are either already available or expected in
the near future, target the following diseases: The GAVI Board
selected these diseases from an origin